CNCT19
IIT2020013
Phase 2 mab completed
Quick answer
CNCT19 for Large B-cell Lymphoma is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Large B-cell Lymphoma
- Phase
- Phase 2
- Modality
- mab
- Status
- completed